Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 187,353 $ 130,572
Short-term restricted cash 982 105
Short-term investments 18,529 0
Accounts receivable, net 170,971 119,724
Inventory 160,544 131,703
Prepaid expenses and other current assets 24,745 22,000
Total current assets 563,124 404,104
Long-term restricted cash 22 1,061
Property and equipment, net 79,018 60,924
Leased right-of-use assets 28,515 27,269
Intangible assets, net 109,316 152,540
Goodwill 306,739 306,668
Deferred tax assets 66,491 89,168
Other long-term assets 26,800 8,650
Total assets 1,180,025 1,050,384
Current liabilities:    
Accounts payable 68,576 52,976
Accrued price protection liability 113,274 40,509
Accrued expenses and other current liabilities 100,155 57,268
Accrued compensation 59,081 56,642
Total current liabilities 341,086 207,395
Long-term lease liabilities 23,353 24,640
Long-term debt 121,757 306,153
Other long-term liabilities 17,444 22,998
Total liabilities 503,640 561,186
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 550,000 shares authorized; 78,745 shares issued and outstanding at December 31, 2022 and 76,778 shares issued and outstanding December 31, 2021 8 8
Additional paid-in capital 722,778 657,485
Accumulated other comprehensive income (loss) (1,021) 2,125
Accumulated deficit (45,380) (170,420)
Total stockholders’ equity 676,385 489,198
Total liabilities and stockholders’ equity $ 1,180,025 $ 1,050,384